HGI-003

N/A

Report date: 2024/09/06 16:21:09

Base Information

Drug NameHGI-003
Drug Alias NameHGI-003
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Lentiviral vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsX-Linked Combined Immunodeficiency Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenzhen Hemogen Gene Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Hemogen Gene Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsX-Linked Combined Immunodeficiency Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A